This case emphasizes that even de novo STAG2 truncating variants can produce markedly different organ-specific outcomes, from mild developmental delay to life-threatening cardiac malformations, highlighting the need for individualized clinical surveillance and long-term follow-up. This evidence concerns the gene STAG2 and Global developmental delay.